SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Philippa Fibert, Case report of two siblings with multi- morbidities receiving homeopathic treatment for one year, European Journal of Integrative Medicine, 2016, 8, 2, 141

    CrossRef

  2. 2
    Emma K. Genco, Jeri E. Forster, Hanna Flaten, Foster Goss, Kennon J. Heard, Jason Hoppe, Andrew A. Monte, Clinically Inconsequential Alerts: The Characteristics of Opioid Drug Alerts and Their Utility in Preventing Adverse Drug Events in the Emergency Department, Annals of Emergency Medicine, 2016, 67, 2, 240

    CrossRef

  3. 3
    O Alagoz, D Durham, K Kasirajan, Cost-effectiveness of one-time genetic testing to minimize lifetime adverse drug reactions, The Pharmacogenomics Journal, 2016, 16, 2, 129

    CrossRef

  4. 4
    Patrick Kitzman, Darrin Cecil, Jimmi Hatton Kolpek, The risks of polypharmacy following spinal cord injury, The Journal of Spinal Cord Medicine, 2016, 1

    CrossRef

  5. 5
    Betul Okuyan, Bedis Babi, Mesut Sancar, Pınar Ay, Emre Yücel, Aylin Yücel, Fikret Vehbi Izzettin, Validation of the Turkish version of medication regimen complexity index among elderly patients, Journal of Evaluation in Clinical Practice, 2016, 22, 3
  6. 6
    Natali Jokanovic, Edwin C. K. Tan, Michael J. Dooley, Carl M. Kirkpatrick, Rohan A. Elliott, J. Simon Bell, Why is polypharmacy increasing in aged care facilities? The views of Australian health care professionals, Journal of Evaluation in Clinical Practice, 2016, 22, 3
  7. 7
    Bruce Guthrie, Peter T Donnan, Douglas J Murphy, Boikanyo Makubate, Tobias Dreischulte, Bad apples or spoiled barrels? Multilevel modelling analysis of variation in high-risk prescribing in Scotland between general practitioners and between the practices they work in, BMJ Open, 2015, 5, 11, e008270

    CrossRef

  8. 8
    Carli Michèle Wilmer, Victor Johan Bernard Huiskes, Stephanie Natsch, Alexander Johannes Maria Rennings, Bartholomeus Johannnes Frederikus van den Bemt, Jacqueline Maria Bos, Drug-related problems in a clinical setting: a literature review and cross-sectional study evaluating factors to identify patients at risk, European Journal of Hospital Pharmacy: Science and Practice, 2015, 22, 4, 229

    CrossRef

  9. 9
    A. L. Hersh, J. S. Gerber, L. A. Hicks, A. T. Pavia, Lessons Learned in Antibiotic Stewardship: Fluoroquinolone Use in Pediatrics, Journal of the Pediatric Infectious Diseases Society, 2015, 4, 1, 57

    CrossRef

  10. 10
    Bruce Guthrie, Ning Yu, Douglas Murphy, Peter T Donnan, Tobias Dreischulte, Measuring prevalence, reliability and variation in high-risk prescribing in general practice using multilevel modelling of observational data in a population database, Health Services and Delivery Research, 2015, 3, 42, 1

    CrossRef

  11. 11
    Encarnación Blanco-Reina, Gabriel Ariza-Zafra, Ricardo Ocaña-Riola, Matilde León-Ortíz, Inmaculada Bellido-Estévez, Optimizing elderly pharmacotherapy: polypharmacy vs. undertreatment. Are these two concepts related?, European Journal of Clinical Pharmacology, 2015, 71, 2, 199

    CrossRef

  12. 12
    Natali Jokanovic, Edwin C.K. Tan, Michael J. Dooley, Carl M. Kirkpatrick, J. Simon Bell, Prevalence and Factors Associated With Polypharmacy in Long-Term Care Facilities: A Systematic Review, Journal of the American Medical Directors Association, 2015, 16, 6, 535.e1

    CrossRef

  13. 13
    Avi Baehr, Juliet C. Peña, Dale J. Hu, Racial and Ethnic Disparities in Adverse Drug Events: A Systematic Review of the Literature, Journal of Racial and Ethnic Health Disparities, 2015, 2, 4, 527

    CrossRef

  14. 14
    Tom Marrs, Adam T Fox, Gideon Lack, George du Toit, The diagnosis and management of antibiotic allergy in children: Systematic review to inform a contemporary approach, Archives of Disease in Childhood, 2015, 100, 6, 583

    CrossRef

  15. 15
    Bruce Guthrie, Boikanyo Makubate, Virginia Hernandez-Santiago, Tobias Dreischulte, The rising tide of polypharmacy and drug-drug interactions: population database analysis 1995–2010, BMC Medicine, 2015, 13, 1

    CrossRef

  16. 16
    Robert L Maher, Joseph Hanlon, Emily R Hajjar, Clinical consequences of polypharmacy in elderly, Expert Opinion on Drug Safety, 2014, 13, 1, 57

    CrossRef

  17. 17
    Terri R. Fried, John O'Leary, Virginia Towle, Mary K. Goldstein, Mark Trentalange, Deanna K. Martin, Health Outcomes Associated with Polypharmacy in Community-Dwelling Older Adults: A Systematic Review, Journal of the American Geriatrics Society, 2014, 62, 12
  18. 18
    P. C. Burcham, Science in Two Minds: Reflections on the Missional Disunity Within Contemporary Medicine, Christian Bioethics, 2014, 20, 3, 359

    CrossRef

  19. 19
    Juha Sinnemäki, Leena K. Saastamoinen, Sara Hannula, Sirpa Peura, Marja Airaksinen, Starting an automated dose dispensing service provided by community pharmacies in Finland, International Journal of Clinical Pharmacy, 2014, 36, 2, 345

    CrossRef

  20. 20
    Robert Eriksson, Peter Bjødstrup Jensen, Sune Frankild, Lars Juhl Jensen, Søren Brunak, Dictionary construction and identification of possible adverse drug events in Danish clinical narrative text, Journal of the American Medical Informatics Association, 2013, 20, 5, 947

    CrossRef

  21. 21
    Eslie H. Dennis, Elizabeth G. Walker, Amanda F. Baker, Richard T. Miller, Opportunities and Challenges of Safety Biomarker Qualification: Perspectives from the Predictive Safety Testing Consortium, Drug Development Research, 2013, 74, 2
  22. 22
    Jennifer Jacobs, Peter Fisher, Polypharmacy, multimorbidity and the value of integrative medicine in public health, European Journal of Integrative Medicine, 2013, 5, 1, 4

    CrossRef

  23. 23
    Adam B. Woolley, Charles A. Berds, Roger A. Edwards, Debra Copeland, Margarita V. DiVall, Potential Cost Avoidance of Pharmacy Students’ Patient Care Activities During Advanced Pharmacy Practice Experiences, American Journal of Pharmaceutical Education, 2013, 77, 8, 164

    CrossRef

  24. 24
    Mackenzie Williams, Gregory M. Peterson, Peter C. Tenni, Ivan K. Bindoff, A clinical knowledge measurement tool to assess the ability of community pharmacists to detect drug-related problems, International Journal of Pharmacy Practice, 2012, 20, 4
  25. 25
    Mackenzie Williams, Gregory M. Peterson, Peter C. Tenni, Ivan K. Bindoff, Andrew C. Stafford, DOCUMENT: a system for classifying drug-related problems in community pharmacy, International Journal of Clinical Pharmacy, 2012, 34, 1, 43

    CrossRef

  26. 26
    Ute Richarz, Adam Jacobs, Edoardo Spina, How frequently are contraindicated or warned against combinations of drugs prescribed to patients receiving long-term opioid therapy for chronic pain?, Pharmacoepidemiology and Drug Safety, 2012, 21, 5
  27. 27
    Lucien Roulet, Nathalie Asseray, Martin Dary, Anne Chiffoleau, Gilles Potel, Françoise Ballereau, Implementing a clinical pharmacy survey of adverse drug events in a French emergency department, International Journal of Clinical Pharmacy, 2012, 34, 6, 902

    CrossRef

  28. 28
    Graham Ellis, Older people in hospital: The benefits of doing the right thing and the consequences of not choosing to do the right thing, Revista Española de Geriatría y Gerontología, 2012, 47, 3, 91

    CrossRef

  29. 29
    Roschelle Heuberger, Polypharmacy and Food–Drug Interactions Among Older Persons: A Review, Journal of Nutrition in Gerontology and Geriatrics, 2012, 31, 4, 325

    CrossRef

  30. 30
    Bhavik M. Shah, Emily R. Hajjar, Polypharmacy, Adverse Drug Reactions, and Geriatric Syndromes, Clinics in Geriatric Medicine, 2012, 28, 2, 173

    CrossRef

  31. 31
    Susan Robinson, Jill Howie-Esquivel, David Vlahov, Readmission Risk Factors after Hospital Discharge Among the Elderly, Population Health Management, 2012, 15, 6, 338

    CrossRef

  32. 32
    Gotaro Kojima, Christina Bell, Bruce Tamura, Michiko Inaba, Karen Lubimir, Patricia Lanoie Blanchette, Wendy Iwasaki, Kamal Masaki, Reducing Cost by Reducing Polypharmacy: The Polypharmacy Outcomes Project, Journal of the American Medical Directors Association, 2012, 13, 9, 818.e11

    CrossRef

  33. 33
    Daniel R. Touchette, Andrew L. Masica, Rowena J. Dolor, Glen T. Schumock, Young Ku Choi, Yoonsang Kim, Scott R. Smith, Safety-focused medication therapy management: A randomized controlled trial, Journal of the American Pharmacists Association, 2012, 52, 5, 603

    CrossRef

  34. 34
    Daniel J. Safer, Age-Grouped Differences in Adverse Drug Events from Psychotropic Medication, Journal of Child and Adolescent Psychopharmacology, 2011, 21, 4, 299

    CrossRef

  35. 35
    Current awareness: Pharmacoepidemiology and drug safety, Pharmacoepidemiology and Drug Safety, 2010, 19, 12
  36. 36
    Mikkel Christensen, Andreas Lundh, Medication review in hospitalised patients to reduce morbidity and mortality, The Cochrane Library,
  37. 37
    Gina DeSevo Bellotti, Emily R. Hajjar, Polypharmacy, The Encyclopedia of Adulthood and Aging,